Effects of exercise on C-reactive protein, inflammatory cytokine and adipokine in patients with type 2 diabetes: A meta-analysis of randomized controlled trials

Metabolism: Clinical and Experimental

Volumn 63, Issue 3, 2014, Pages 431-440

  Hayashino, Yasuaki ^a,b   Jackson, Jeffrey L ^c   Hirata, Takumi ^b   Fukumori, Norio ^b   Nakamura, Fumiaki ^b   Fukuhara, Shunichi ^b   Tsujii, Satoru ^a   Ishii, Hitoshi ^a  

^a TENRI HOSPITAL   (Japan)

^b KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c CLEMENT J ZABLOCKI VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Adipokine; Diabetes; Exercise; Inflammation

Indexed keywords

ADIPOKINE; DIABETES; EXERCISE; INFLAMMATION;

ADIPOKINES; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; DIABETES MELLITUS, TYPE 2; EXERCISE; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-6; MALE; MIDDLE AGED;

EID: 84894098449     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2013.08.018     Document Type: Article

References (50)

1. S. Wild, G. Roglic, A. Green, R. Sicree, and H. King Global prevalence of diabetes: estimates for the year 2000 and projections for 2030 Diabetes Care 27 2004 1047 1053
2. S. Dagogo-Jack Primary prevention of type-2 diabetes in developing countries J Natl Med Assoc 98 2006 415 419
3. D. Holst, and P.A. Grimaldi New factors in the regulation of adipose differentiation and metabolism Curr Opin Lipidol 13 2002 241 245
4. P.J. Havel Control of energy homeostasis and insulin action by adipocyte hormones: leptin, acylation stimulating protein, and adiponectin Curr Opin Lipidol 13 2002 51 59
5. A. Barseghian, D. Gawande, and M. Bajaj Adiponectin and vulnerable atherosclerotic plaques J Am Coll Cardiol 57 2011 761 770
6. N.E. Gulcelik, A. Usman, and A. Gürlek Role of adipocytokines in predicting the development of diabetes and its late complications Endocrine 36 2009 397 403
7. P. Arner Insulin resistance in type 2 diabetes - role of the adipokines Curr Mol Med 5 2005 333 339
8. M.G. Pepys The acute phase response and C-reactive protein D.J. Weatherall, J.G. Ledingam, D.A. Warrell, Oxford textbook of medicine 3rd ed. 1995 Oxford University Press Oxford (England) [eds. Oxford textbook of medicine, (3rd ed.). Oxford (England) Oxford (England)]
9. P.M. Ridker, N. Rifai, L. Rose, J.E. Buring, and N.R. Cook Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events N Engl J Med 347 2002 1557 1565
10. Executive summary: standards of medical care in diabetes Diabetes Care 34 Suppl 1 2011 S4 S10
11. Standards of medical care in diabetes Diabetes Care 33 Suppl 1 2010 S11 S61
12. S. Balducci, S. Zanuso, A. Nicolucci, F. Fernando, S. Cavallo, P. Cardelli, S. Fallucca, E. Alessi, C. Letizia, A. Jimenez, F. Fallucca, and G. Pugliese Anti-inflammatory effect of exercise training in subjects with type 2 diabetes and the metabolic syndrome is dependent on exercise modalities and independent of weight loss Nutr Metab Cardiovasc Dis 20 2010 608 617
13. I. Giannopoulou, B. Fernhall, R. Carhart, R.S. Weinstock, T. Baynard, and A. Figueroa et al. Effects of diet and/or exercise on the adipocytokine and inflammatory cytokine levels of postmenopausal women with type 2 diabetes Metabolism 54 2005 866 875
14. N.P. Kadoglou, F. Iliadis, N. Angelopoulou, D. Perrea, G. Ampatzidis, and C.D. Liapis et al. The anti-inflammatory effects of exercise training in patients with type 2 diabetes mellitus Eur J Cardiovasc Prev Rehabil 14 2007 837 843
15. N.P. Kadoglou, F. Iliadis, C.D. Liapis, D. Perrea, N. Angelopoulou, and M. Alevizos Beneficial effects of combined treatment with rosiglitazone and exercise on cardiovascular risk factors in patients with type 2 diabetes Diabetes Care 30 2007 2242 2244
16. N.P. Kadoglou, I.S. Vrabas, N. Sailer, A. Kapelouzou, G. Fotiadis, G. Noussios, P.E. Karayannacos, and N. Angelopoulou Exercise ameliorates serum MMP-9 and TIMP-2 levels in patients with type 2 diabetes Diabetes Metab 36 2010 144 151
17. N.P. Kadoglou, F. Iliadis, N. Sailer, Z. Athanasiadou, I. Vitta, and A. Kapelouzou et al. Exercise training ameliorates the effects of rosiglitazone on traditional and novel cardiovascular risk factors in patients with type 2 diabetes mellitus Metabolism 59 2010 599 607
18. N.P. Kadoglou, D. Perrea, F. Iliadis, N. Angelopoulou, C. Liapis, and M. Alevizos et al. Exercise reduces resistin and inflammatory cytokines in patients with type 2 diabetes Diabetes Care 30 2007 719 721
19. Y.H. Ku, K.A. Han, H. Ahn, H. Kwon, B.K. Koo, H.C. Kim, and K.W. Mi Resistance exercise did not alter intramuscular adipose tissue but reduced retinol-binding protein-4 concentration in individuals with type 2 diabetes mellitus J Int Med Res 38 2010 782 791
20. A.R. Middlebrooke, L.M. Elston, K.M. Macleod, D.M. Mawson, C.I. Ball, and A.C. Shore et al. Six months of aerobic exercise does not improve microvascular function in type 2 diabetes mellitus Diabetologia 49 2006 2263 2271
21. T.P. Wycherley, M. Noakes, P.M. Clifton, X. Cleanthous, J.B. Keogh, and G.D. Brinkworth A high-protein diet with resistance exercise training improves weight loss and body composition in overweight and obese patients with type 2 diabetes Diabetes Care 33 2010 969 976
22. A. Loimaala, K. Groundstroem, M. Rinne, A. Nenonen, H. Huhtala, and J. Parkkari et al. Effect of long-term endurance and strength training on metabolic control and arterial elasticity in patients with type 2 diabetes mellitus Am J Cardiol 103 2009 972 977
23. S. Okada, A. Hiuge, H. Makino, A. Nagumo, H. Takaki, H. Konishi, Y. Goto, Y. Yoshimasa, and Y. Miyamoto Effect of exercise intervention on endothelial function and incidence of cardiovascular disease in patients with type 2 diabetes J Atheroscler Thromb 17 2010 828 833
24. S.H. Kim, S.J. Lee, E.S. Kang, S. Kang, K.Y. Hur, and H.J. Lee et al. Effects of lifestyle modification on metabolic parameters and carotid intima-media thickness in patients with type 2 diabetes mellitus Metabolism 55 2006 1053 1059
25. K. Dickersin, R. Scherer, and C. Lefebvre Identifying relevant studies for systematic reviews BMJ 309 1994 1286 1291
26. J.P.T. Higgins S. Green, Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011] 2011 The Cochrane Collaboration [Available from www.cochrane-handbook.org.]
27. A.P. Verhagen, H.C. de Vet, R.A. de Bie, A.G. Kessels, M. Boers, and L.M. Bouter et al. The Delphi list: a criteria list for quality assessment of randomized clinical trials for conducting systematic reviews developed by Delphi consensus J Clin Epidemiol 51 1998 1235 1241
28. R. DerSimonian, and N. Laird Meta-analysis in clinical trials Control Clin Trials 7 1986 177 188
29. J.P. Higgins, S.G. Thompson, J.J. Deeks, and D.G. Altman Measuring inconsistency in meta-analyses BMJ 327 2003 557 560
30. R.M. Harbord, and J.P.T. Higgins Meta-regression in Stata J.A.C. Sterne, H.J. Newton, N.J. Cox, Meta-analysis in Stata 2009 Stata Press College Station, TX
31. C.B. Begg, and M. Mazumdar Operating characteristics of a rank correlation test for publication bias Biometrics 50 1994 1088 1101
32. M. Egger, G. Davey Smith, M. Schneider, and C. Minder Bias in meta-analysis detected by a simple, graphical test BMJ 315 1997 629 634
33. S. Duval, and R. Tweedie Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis Biometrics 56 2000 455 463
34. M.L. Jorge, V.N. de Oliveira, N.M. Resende, L.F. Paraiso, A. Calixto, and A.L. Diniz et al. The effects of aerobic, resistance, and combined exercise on metabolic control, inflammatory markers, adipocytokines, and muscle insulin signaling in patients with type 2 diabetes mellitus Metabolism 60 2011 1244 1252
35. P. Calabro, D.W. Chang, J.T. Willerson, and E.T. Yeh Release of C-reactive protein in response to inflammatory cytokines by human adipocytes: linking obesity to vascular inflammation J Am Coll Cardiol 46 2005 1112 1113
36. K. Yasojima, C. Schwab, E.G. McGeer, and P.L. McGeer Generation of C-reactive protein and complement components in atherosclerotic plaques Am J Pathol 158 2001 1039 1051
37. B. Fève, and J.P. Bastard The role of interleukins in insulin resistance and type 2 diabetes mellitus Nat Rev Endocrinol 5 2009 305 311
38. K. Hotta, T. Funahashi, Y. Arita, M. Takahashi, M. Matsuda, and Y. Okamoto et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients Arterioscler Thromb Vasc Biol 20 2000 1595 1599
39. M. Cnop, P.J. Havel, K.M. Utzschneider, D.B. Carr, M.K. Sinha, and E.J. Boyko et al. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex Diabetologia 46 2003 459 469
40. M. Côté, A. Cartier, A.Q. Reuwer, B.J. Arsenault, I. Lemieux, and J.P. Després et al. Adiponectin and risk of coronary heart disease in apparently healthy men and women (from the EPIC-Norfolk Prospective Population Study) Am J Cardiol 108 2011 367 373
41. G. Milan, M. Granzotto, A. Scarda, A. Calcagno, C. Pagano, and G. Federspil et al. Resistin and adiponectin expression in visceral fat of obese rats: effect of weight loss Obes Res 10 2002 1095 1103
42. W.S. Yang, W.J. Lee, T. Funahashi, S. Tanaka, Y. Matsuzawa, and C.L. Chao et al. Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin J Clin Endocrinol Metab 86 2001 3815 3819
43. S.N. Davison, and C. Simpson Hope and advance care planning in patients with end stage renal disease: qualitative interview study BMJ 333 2006 886
44. L.M. Belalcazar, W. Lang, S.M. Haffner, R.C. Hoogeveen, F.X. Pi-Sunyer, and D.C. Schwenke et al. Adiponectin and the mediation of HDL-cholesterol change with improved lifestyle: the Look AHEAD Study J Lipid Res 53 2012 2726 2733
45. R.V. Considine, M.K. Sinha, M.L. Heiman, A. Kriauciunas, T.W. Stephens, and M.R. Nyce et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans N Engl J Med 334 1996 292 295
46. J.L. Halaas, K.S. Gajiwala, M. Maffei, S.L. Cohen, B.T. Chait, and D. Rabinowitz et al. Weight-reducing effects of the plasma protein encoded by the obese gene Science 269 1995 543 546
47. A.M. Wallace, A.D. McMahon, C.J. Packard, A. Kelly, J. Shepherd, and A. Gaw et al. Plasma leptin and the risk of cardiovascular disease in the West of Scotland Coronary Prevention Study (WOSCOPS) Circulation 104 2001 3052 3056
48. S. Söderberg, B. Ahrén, B. Stegmayr, O. Johnson, P.G. Wiklund, and L. Weinehall et al. Leptin is a risk marker for first-ever hemorrhagic stroke in a population-based cohort Stroke 30 1999 328 337
49. Health TNIo Weight loss does not lower heart disease risk from type 2 diabetes 2013 [In:]
50. The National Institutes of Health Weight loss does not lower heart disease risk from type 2 diabetes 2013 [In:]